SBTX — Skinbiotherapeutics Share News
0.000.00%
- £18.30m
- £15.56m
- £0.13m
REG - SkinBioTherapeutics - £5.0m Convertible Bond Facility & First Drawdown
AnnouncementREG - SkinBioTherapeutics - Acquisition of Dermatonics
AnnouncementREG - SkinBioTherapeutics - Result of AGM
AnnouncementREG - SkinBioTherapeutics - Update on transaction timelines to early 2024
AnnouncementREG - SkinBioTherapeutics - Notice of AGM and posting of Annual Report
AnnouncementREG - SkinBioTherapeutics - Final Results
AnnouncementREG - SkinBioTherapeutics - AxisBiotix-Ps™ to launch on Amazon UK
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
AnnouncementREG - SkinBioTherapeutics - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 22/11/2023
AnnouncementREG - SkinBioTherapeutics - Update regarding Nominated Adviser and Broker
AnnouncementREG - SkinBioTherapeutics - Result of Retail Offer
AnnouncementREG - SkinBioTherapeutics - Result of Placing
AnnouncementREG - SkinBioTherapeutics - Placing and Retail Offer
AnnouncementREG - SkinBioTherapeutics - Retail Offer
AnnouncementREG - SkinBioTherapeutics - Acne study, Trading and Auditor updates
AnnouncementREG - SkinBioTherapeutics - Extension of Croda contract for SkinBiotix™
AnnouncementREG - SkinBioTherapeutics - health authority approval for AxisBiotix in France
AnnouncementREG - SkinBioTherapeutics - Update on acne programme
Announcement